Rasmussen's encephalitis is characterized by relatively lower production of IFN-β and activated cytotoxic T cell upon herpes viruses infection.
Herpes viruses
IFI16
IFN-β
Rasmussen’s encephalitis
STING
Journal
Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974
Informations de publication
Date de publication:
26 Mar 2022
26 Mar 2022
Historique:
received:
08
08
2021
accepted:
14
12
2021
entrez:
26
3
2022
pubmed:
27
3
2022
medline:
8
4
2022
Statut:
epublish
Résumé
The etiology of Rasmussen's encephalitis (RE), a rare chronic neurological disorder characterized by CD8+ T cell infiltration and unihemispheric brain atrophy, is still unknown. Various human herpes viruses (HHVs) have been detected in RE brain, but their contribution to RE pathogenesis is unclear. HHVs infection and relevant immune response were compared among brain tissues from RE, temporal lobe epilepsy (TLE) and traumatic brain injury (TBI) patients. Viral antigen or genome, CD8+ T cells, microglia and innate immunity molecules were analyzed by immunohistochemical staining, DNA dot blot assay or immunofluorescence double staining. Cytokines were measured by multiplex flow cytometry. Cell apoptosis was visualized by TUNEL staining. Viral infection, immune response and the severity of unihemispheric atrophy were subjected to correlation analysis. Antigens of various HHVs were prevalent in RE and TLE brains, and the cumulative viral score of HHVs positively correlated with the unihemispheric atrophy in RE patients. CD8+ T cells infiltration were observed in both RE and TLE brains and showed co-localization with HHV antigens, but their activation, as revealed by Granzyme B (GZMB) release and apoptosis, was found only in RE. In comparison to TLE, RE brain tissues contained higher level of inflammatory cytokines, but the interferon-β level, which was negatively correlated with cumulative viral score, was relatively lower. In line with this, the DNA sensor STING and IFI16, rather than other innate immunity signaling molecules, were insufficiently activated in RE. Compared with TBI, both RE and TLE had prevalently HHV infection and immune response in brain tissues. However, in comparison to TLE, RE showed insufficient activation of antiviral innate immunity but overactivation of cytotoxic T cells. Our results show the relatively lower level of antiviral innate immunity and overactivation of cytotoxic T cells in RE cases upon HHV infection, the overactivated T cells might be a compensate to the innate immunity but the causative evidence is lack in our study and need more investigation in the future.
Sections du résumé
BACKGROUND
BACKGROUND
The etiology of Rasmussen's encephalitis (RE), a rare chronic neurological disorder characterized by CD8+ T cell infiltration and unihemispheric brain atrophy, is still unknown. Various human herpes viruses (HHVs) have been detected in RE brain, but their contribution to RE pathogenesis is unclear.
METHODS
METHODS
HHVs infection and relevant immune response were compared among brain tissues from RE, temporal lobe epilepsy (TLE) and traumatic brain injury (TBI) patients. Viral antigen or genome, CD8+ T cells, microglia and innate immunity molecules were analyzed by immunohistochemical staining, DNA dot blot assay or immunofluorescence double staining. Cytokines were measured by multiplex flow cytometry. Cell apoptosis was visualized by TUNEL staining. Viral infection, immune response and the severity of unihemispheric atrophy were subjected to correlation analysis.
RESULTS
RESULTS
Antigens of various HHVs were prevalent in RE and TLE brains, and the cumulative viral score of HHVs positively correlated with the unihemispheric atrophy in RE patients. CD8+ T cells infiltration were observed in both RE and TLE brains and showed co-localization with HHV antigens, but their activation, as revealed by Granzyme B (GZMB) release and apoptosis, was found only in RE. In comparison to TLE, RE brain tissues contained higher level of inflammatory cytokines, but the interferon-β level, which was negatively correlated with cumulative viral score, was relatively lower. In line with this, the DNA sensor STING and IFI16, rather than other innate immunity signaling molecules, were insufficiently activated in RE.
CONCLUSIONS
CONCLUSIONS
Compared with TBI, both RE and TLE had prevalently HHV infection and immune response in brain tissues. However, in comparison to TLE, RE showed insufficient activation of antiviral innate immunity but overactivation of cytotoxic T cells. Our results show the relatively lower level of antiviral innate immunity and overactivation of cytotoxic T cells in RE cases upon HHV infection, the overactivated T cells might be a compensate to the innate immunity but the causative evidence is lack in our study and need more investigation in the future.
Identifiants
pubmed: 35337341
doi: 10.1186/s12974-022-02379-0
pii: 10.1186/s12974-022-02379-0
pmc: PMC8957159
doi:
Substances chimiques
Interferon-beta
77238-31-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
70Subventions
Organisme : National Natural Science Foundation of China
ID : 81972979
Organisme : National Natural Science Foundation of China
ID : U1902210
Organisme : National Natural Science Foundation of China
ID : 81871641
Organisme : Project of High-level Teachers in Beijing Municipal Universities in the Period of 13th Five-year Plan
ID : IDHT20190510
Informations de copyright
© 2022. The Author(s).
Références
J Infect Dis. 2015 Oct 1;212(7):1014-21
pubmed: 25840441
J Clin Invest. 2018 May 1;128(5):2000-2009
pubmed: 29629902
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):E3008-17
pubmed: 23027953
Eur J Paediatr Neurol. 2016 Mar;20(2):222-227
pubmed: 26785913
Physiol Rev. 2011 Apr;91(2):461-553
pubmed: 21527731
Neurobiol Dis. 2009 Jun;34(3):432-40
pubmed: 19285133
Epilepsia. 2005;46 Suppl 5:152-8
pubmed: 15987271
Brain. 2005 Mar;128(Pt 3):454-71
pubmed: 15689357
Nat Commun. 2016 Apr 04;7:11153
pubmed: 27040081
Epilepsy Res. 2017 May;132:109-115
pubmed: 28399506
Immunity. 2003 May;18(5):593-603
pubmed: 12753737
Adv Virus Res. 2015;92:63-100
pubmed: 25701886
Nat Immunol. 2016 Jul 19;17(8):906-13
pubmed: 27434011
Trends Microbiol. 2017 Mar;25(3):229-241
pubmed: 27956142
Ann Clin Transl Neurol. 2021 Mar;8(3):558-570
pubmed: 33465303
Virol Sin. 2017 Apr;32(2):115-121
pubmed: 28303446
J Virol. 2017 Jun 26;91(14):
pubmed: 28468883
Virol J. 2017 Nov 13;14(1):221
pubmed: 29132393
Lancet Neurol. 2014 Feb;13(2):195-205
pubmed: 24457189
Curr Opin Neurol. 2002 Apr;15(2):197-200
pubmed: 11923635
Viruses. 2017 Jul 24;9(7):
pubmed: 28737715
Lancet. 1991 Jun 22;337(8756):1551-2
pubmed: 1675405
J Clin Neurosci. 2016 Mar;25:96-104
pubmed: 26675623
Acta Neuropathol. 2019 Apr;137(4):619-635
pubmed: 30663001
Lancet. 1989 Feb 4;1(8632):279-80
pubmed: 2563444
Pediatrics. 1997 Aug;100(2 Pt 1):163-71
pubmed: 9240794
Brain. 2002 Aug;125(Pt 8):1751-9
pubmed: 12135966
Nat Rev Microbiol. 2008 Mar;6(3):211-21
pubmed: 18264117
Epileptic Disord. 2016 Jun 1;18(2):204-10
pubmed: 27248684
Folia Microbiol (Praha). 2017 Mar;62(2):151-156
pubmed: 27858281
J Exp Med. 2000 May 1;191(9):1459-66
pubmed: 10790421
PLoS Pathog. 2010 Aug 19;6(8):e1001051
pubmed: 20808900
J Neurosurg Pediatr. 2014 Dec;14(6):573-84
pubmed: 25303156
J Med Virol. 2018 Sep;90(9):1532-1540
pubmed: 29727474
Virol Sin. 2017 Oct;32(5):423-430
pubmed: 29116594
Science. 1994 Jul 29;265(5172):648-51
pubmed: 8036512